Follow-up of the FRUIT-RCT; aspirin resistance and cardiovascular risk factors in women after recurrent hypertensive disorders in pregnancy

Follow-up of the FRUIT-RCT; aspirin resistance and cardiovascular risk factors in women after recurrent hypertensive disorders in pregnancy - Follow-up FRUIT-RCT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON41727

Enrollment

Registered

2015-03-02

Start date

2015-04-20

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aspirin resistance and cardiovascular risk factors

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: For question 1a en 2: Inclusion in the FRUIT-RCT and living in the Netherlands. ;For question 1b: indication of aspirin use during pregnancy.

Exclusion criteria

Exclusion criteria: - Diabetes Mellitus; - Drugs that are known to alter platelet function (e.g. NSAID*s, tirofiban, eptifibatide, abciximab, clopidogrel, prasugel, ticagrelor, beta-lactam antibiotics, dextran, SSRI*s, clomipramine & amitriptyline, dipyridamole, verapamil, diltiazem , ginkgo biloba, ginseng, St John*s wort) within 2 weeks before testing. - Major surgical procedure within one week before enrollment; - Recent cardiovascular event

Design outcomes

Secondary

Measure	Time frame
Metabolic syndrome	—

Primary

Measure	Time frame
Aspirin resistance and cardiovascular risk factors	—

Countries

Netherlands

Outcome results